Q2 2022 Earnings Estimate for Oak Street Health, Inc. (NYSE:OSH) Issued By William Blair

Oak Street Health, Inc. (NYSE:OSHGet Rating) – Stock analysts at William Blair raised their Q2 2022 earnings per share (EPS) estimates for Oak Street Health in a report issued on Tuesday, May 3rd. William Blair analyst R. Daniels now anticipates that the company will post earnings of ($0.50) per share for the quarter, up from their prior forecast of ($0.55). William Blair also issued estimates for Oak Street Health’s Q3 2022 earnings at ($0.61) EPS, Q4 2022 earnings at ($0.67) EPS, FY2022 earnings at ($2.19) EPS, Q1 2023 earnings at ($0.35) EPS, Q2 2023 earnings at ($0.39) EPS, Q4 2023 earnings at ($0.43) EPS and FY2023 earnings at ($1.55) EPS.

Several other equities analysts have also recently issued reports on OSH. Raymond James reduced their price target on shares of Oak Street Health from $60.00 to $35.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 18th. SVB Leerink boosted their price target on shares of Oak Street Health from $17.00 to $23.00 and gave the company a “market perform” rating in a research report on Wednesday, March 2nd. Barclays upped their price objective on shares of Oak Street Health from $27.00 to $31.00 and gave the stock an “overweight” rating in a report on Tuesday, April 19th. Canaccord Genuity Group cut their price objective on shares of Oak Street Health from $49.00 to $29.00 in a report on Wednesday, March 2nd. Finally, The Goldman Sachs Group cut their price objective on shares of Oak Street Health from $68.00 to $37.00 and set a “buy” rating on the stock in a report on Monday, March 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Oak Street Health presently has a consensus rating of “Buy” and an average price target of $39.79.

Shares of NYSE OSH opened at $18.25 on Friday. Oak Street Health has a 1 year low of $13.72 and a 1 year high of $65.22. The company has a current ratio of 2.06, a quick ratio of 2.06 and a debt-to-equity ratio of 16.10. The company’s 50-day moving average is $23.18 and its 200 day moving average is $27.44.

Oak Street Health (NYSE:OSHGet Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.04). Oak Street Health had a negative net margin of 26.82% and a negative return on equity of 308.72%. The company had revenue of $513.80 million for the quarter, compared to analysts’ expectations of $506.82 million. During the same quarter in the prior year, the firm earned ($0.29) EPS. Oak Street Health’s quarterly revenue was up 73.2% compared to the same quarter last year.

In other Oak Street Health news, insider Geoffrey M. Price sold 60,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 5th. The shares were sold at an average price of $26.56, for a total transaction of $1,593,600.00. Following the completion of the sale, the insider now directly owns 3,871,377 shares of the company’s stock, valued at $102,823,773.12. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Brian Clem sold 15,000 shares of the stock in a transaction on Thursday, March 3rd. The stock was sold at an average price of $21.35, for a total transaction of $320,250.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 290,000 shares of company stock worth $6,776,050. 11.40% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. CI Investments Inc. purchased a new stake in shares of Oak Street Health in the third quarter worth $28,000. Confluence Wealth Services Inc. purchased a new stake in shares of Oak Street Health in the fourth quarter worth $34,000. Benjamin Edwards Inc. increased its stake in shares of Oak Street Health by 9,016.7% in the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company’s stock worth $29,000 after purchasing an additional 1,082 shares in the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Oak Street Health in the fourth quarter worth $46,000. Finally, Fifth Third Bancorp purchased a new position in Oak Street Health during the first quarter valued at $46,000. 91.42% of the stock is owned by hedge funds and other institutional investors.

About Oak Street Health (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Read More

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.